More Europeans Likely To Suffer From Ragweed Allergy

More Europeans Likely To Suffer From Ragweed Allergy
A pan-European study organised by GA²LEN, the Global Allergy and Asthma European Network, tested more than 2000 patients to ragweed allergy in 10 European countries (1). Results published this week on the Allergy journal website (2) show an unexpected extension of allergic sensitisation to ragweed across Europe (3). The study indicates that more and more Europeans are likely to suffer from ragweed allergy or already have an allergy to ragweed.

Applause For National Dementia Strategy From Actress June Brown MBE, UK

Applause For National Dementia Strategy From Actress June Brown MBE, UK
The Lewy Body Society heartily welcomes the publication of the Government's National Dementia Strategy , published last week, for which £150 million has been earmarked for dementia care over the next two years. Measures to be undertaken include the appointment of a senior clinician in every hospital and care home in England, who will be responsible for seeing that the needs of dementia sufferers are met.

PrandiMet(R), First Repaglinide And Metformin HCl Fixed Dose Combination Therapy, Now Available In The United States

PrandiMet(R), First Repaglinide And Metformin HCl Fixed Dose Combination Therapy, Now Available In The United States
Novo Nordisk and Sciele Pharma, Inc., a Shionogi Company, announced the availability of PrandiMet® (repaglinide and metformin HCl) tablets, the first and only fixed-dose combination of the short-acting secretagogue repaglinide (also known as Prandin®) and insulin sensitizer metformin HCl for the treatment of type 2 diabetes in the United States.